On Aug. Preventive Services Task Force posted a draft recommendation statement www. Based on the evidence, the recommendations varied by age group. The USPSTF recommended screening for illicit drug use in adults 18 or older, with the stipulation that screening should be implemented when services for accurate diagnosis, effective treatment and appropriate care can be offered or referred -- a "B" recommendation. The USPSTF also concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening in adolescents and issued an "I" recommendation for that population.
Resource Guide: Screening for Drug Use in General Medical Settings
Conclusions and Recommendations
Not a MyNAP member yet? Register for a free account to start saving and receiving special member only perks. O ver the past 25 years, governments at all levels have made great efforts to reduce drug use in the United States. The number of people incarcerated for drug offenses on any given day has risen from less than 50, in the early s to about , in , including many held in local jails Caulkins and Chandler, Treatment has expanded substantially, and much has been learned about what constitutes effective treatment. And although the prevalence of illegal use is below the highest levels achieved in the late s for marijuana and in the mids for cocaine , it has remained stubbornly high. For many young people today, occasional marijuana use is a part of adolescent development, as it has been since the birth cohort of about
Overcoming Drug Addiction
NCBI Bookshelf. Under the Influence? Drugs and the American Work Force.
Preventive Services Task Force USPSTF recommends screening for illicit drug use in adults, but the evidence is inadequate to ascertain the balance of benefits and harms of screening in adolescents. These findings form the basis of a draft recommendation statement published online Aug. The researchers found that when services for accurate diagnosis of unhealthy drug use or drug use disorders, effective treatment, and appropriate care can be offered or referred, screening has moderate net benefits. Adequate evidence suggested that available screening tools can detect illicit drug use. Three opioid pharmacotherapy agents naltrexone, buprenorphine, and methadone show moderate benefit for reducing relapse and increasing treatment retention.